research use only

Cisapride (R 51619) 5-HT Receptor agonist

Cat.No.S5253

Cisapride (R 51619, Kaudalit, Kinestase, Prepulsid, Presid, Pridesia, Propulsid) is a nonselective 5-HT4 receptor agonist with gastroprokinetic effects.
Cisapride (R 51619) 5-HT Receptor agonist Chemical Structure

Chemical Structure

Molecular Weight: 465.95

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 465.95 Formula

C23H29ClFN3O4

Storage (From the date of receipt)
CAS No. 81098-60-4 -- Storage of Stock Solutions

Synonyms Kaudalit, Kinestase, Prepulsid, Presid, Pridesia, Propulsid Smiles COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F

Solubility

In vitro
Batch:

DMSO : 93 mg/mL ( (199.59 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
hERG channel [1]
9.4 nM
5-HT4 receptor [1]
140 nM(EC50)
In vitro
Cisapride (R 51619) is a 5-HT4 receptor agonist and also a hERG blocker[1], widely used for the treatment of gastrointestinal motility dysfunctions such as gastroesophageal reflux disorder (GERD), chronic intestinal pseudo-obstruction, and slow-transit constipation gastroparesis. It works by promoting gastrointestinal motility through stimulating the release of intestinal acetylcholine from muscarinic receptors. This compound inhibits Kv 4.3 channels stably expressed in Chinese hamster ovary (CEO) cells as well as the current in L-type Ca2+ channels of ventricular myocytes. It inhibited Kv channel current in a concentration-dependent manner independent of its function as a selective serotonin 5-HT4-receptor agonist[2].
References

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map